Mirimanoff René-Olivier, Ozsahin Mahmut, Thariat Juliette, Ozyar Enis, Schick Ulrike, Pehlivan Berrin, Krengli Marco, Pellanda Alessandra Franzetti, Vees Hansjörg, Cai Ling, Scandolaro Luciano, Belkacemi Yazid, Villà Salvador, Igdem Sefik, Lutsyk Myroslav, Miller Robert C
Department of Radiation Oncology, University of Lausanne Medical Center , Lausanne, Switzerland.
Department of Radiation Oncology, Centre Lacassagne , Nice, France.
Rare Tumors. 2014 Aug 6;6(3):5462. doi: 10.4081/rt.2014.5462. eCollection 2014 Jul 30.
Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, to support the study of rare malignancies. The RCN has grown over the years and now includes 130 investigators from twenty-four nations on six continents. The network held its first international symposium in Nice, France, on March 21-22, 2014. The proceedings of that meeting are presented in two companion papers. This manuscript reviews the history of the growth of the RCN and contains the abstracts of fourteen oral presentations made at the meeting of prior RCN studies. From 1993 to 2014, 74 RCN studies have been initiated, of which 54 were completed, 10 are in progress or under analysis, and 9 were stopped due to poor accrual. Forty-four peer reviewed publications have been written on behalf of the RCN.
大约二十年前，罕见癌症网络（RCN）在瑞士洛桑成立，以支持对罕见恶性肿瘤的研究。多年来，RCN不断发展壮大，目前包括来自六大洲24个国家的130名研究人员。该网络于2014年3月21日至22日在法国尼斯举行了首次国际研讨会。那次会议的论文集发表在两篇配套论文中。本手稿回顾了RCN的发展历程，并包含了在之前RCN研究会议上进行的14次口头报告的摘要。从1993年到2014年，已启动了74项RCN研究，其中54项已完成，10项正在进行或正在分析中，9项因入组不佳而停止。代表RCN撰写了44篇经过同行评审的出版物。
